Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotype.

Thrombosis and haemostasis - 1 Sept 1997

Federici A B, Mannucci P M, Stabile F, Canciani M T, Di Rocco N, Miyata S, Ware J, Ruggeri Z M

Abstract excerpt

Type 2B von Willebrand disease (vWD) is typically characterized by enhanced ristocetin-induced platelet aggregation (RIPA) caused by increased von Willebrand factor (vWF) affinity for platelets. Furthermore, absence of larger vWF multimers in plasma is characteristic of the originally described type IIB patients, now considered a subgroup of type 2B. We describe here three affected members of a family presenting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Child
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Point Mutation

Share to Restriction Mapping

Share to Sequence Analysis, DNA

Share to Valine

Share to von Willebrand Factor

Source

Identifiers

PMID: 9308766

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotype.PMID 9308766Read ↗

Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality.Semantic proximity Read ↗

A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis.Semantic proximity Read ↗

Type 2B von Willebrand's disease in thirteen individuals from five unrelated Australian families: phenotype and genotype correlations.Semantic proximity Read ↗

Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets.Semantic proximity Read ↗

[From gene to disease; from mutations in the Von Willebrand factor gene to hemorrhagic diathesis and thrombocytopenia].Semantic proximity Read ↗

Phenotypic Parameters in Genotypically Selected Type 2B von Willebrand Disease Patients: A Large, Single-Center Experience Including a New Novel Mutation.Semantic proximity Read ↗

Genetics of type 2B von Willebrand disease: "true 2B," "tricky 2B," or "not 2B." What are the modifiers of the phenotype?Semantic proximity Read ↗

An update on type 2B von Willebrand disease.Semantic proximity Read ↗

A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function.Semantic proximity Read ↗

2B or not 2B? A diagnosis of von Willebrand disease a lifetime of 86 years in the making.Semantic proximity Read ↗

Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.Semantic proximity Read ↗

von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.